List of Suprax drug patents

Suprax is owned by Lupin Ltd.

Suprax contains Cefixime.

Suprax has a total of 1 drug patent out of which 0 drug patents have expired.

Suprax was authorised for market use on 20 February, 2013.

Suprax is available in for suspension;oral dosage forms.

Suprax can be used as methods for treating bacterial infections.

The generics of Suprax are possible to be released after 14 December, 2028.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9233112 LUPIN LTD Pharmaceutical compositions of cefixime
Dec, 2028

(5 years from now)

Drugs and Companies using CEFIXIME ingredient

Market Authorisation Date: 20 February, 2013

Treatment: Methods for treating bacterial infections

Dosage: FOR SUSPENSION;ORAL

How can I launch a generic of SUPRAX before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in